Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 341

1.

Antifungal susceptibility profiles of rare ascomycetous yeasts.

Pérez-Hansen A, Lass-Flörl C, Lackner M; Rare Yeast Study Group .

J Antimicrob Chemother. 2019 Jun 15. pii: dkz231. doi: 10.1093/jac/dkz231. [Epub ahead of print]

PMID:
31203366
2.

Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.

Schönfeld M, Knackmuss U, Chandorkar P, Hörtnagl P, Hope TJ, Moris A, Bellmann-Weiler R, Lass-Flörl C, Posch W, Wilflingseder D.

Front Immunol. 2019 May 24;10:1123. doi: 10.3389/fimmu.2019.01123. eCollection 2019.

3.

Cryptic species of Aspergillus section Terrei display essential physiological features to cause infection and are similar in their virulence potential in Galleria mellonella.

Lackner M, Obermair J, Naschberger V, Raschbichler LM, Kandelbauer C, Pallua J, Metzlaff J, Furxer S, Lass-Flörl C, Binder U.

Virulence. 2019 Dec;10(1):542-554. doi: 10.1080/21505594.2019.1614382.

PMID:
31169442
4.

The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B.

Stavrou AA, Lackner M, Lass-Flörl C, Boekhout T.

FEMS Yeast Res. 2019 Jun 1;19(4). pii: foz037. doi: 10.1093/femsyr/foz037.

PMID:
31158288
5.

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.

Napolioni V, Pariano M, Borghi M, Oikonomou V, Galosi C, De Luca A, Stincardini C, Vacca C, Renga G, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Carotti A, D'Amico L, Majo F, Russo MC, Ellemunter H, Spolzino A, Mosci P, Brancorsini S, Aversa F, Velardi A, Romani L, Costantini C.

Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019.

6.

Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.

Morio F, Lombardi L, Binder U, Loge C, Robert E, Graessle D, Bodin M, Lass-Flörl C, Butler G, Le Pape P.

J Antimicrob Chemother. 2019 May 18. pii: dkz204. doi: 10.1093/jac/dkz204. [Epub ahead of print]

PMID:
31106355
7.

Whole-Genome Sequencing of the Opportunistic Yeast Pathogen Candida inconspicua Uncovers Its Hybrid Origin.

Mixão V, Hansen AP, Saus E, Boekhout T, Lass-Florl C, Gabaldón T.

Front Genet. 2019 Apr 25;10:383. doi: 10.3389/fgene.2019.00383. eCollection 2019.

8.

Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

Aigner M, Wanner M, Kreidl P, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00138-19. doi: 10.1128/AAC.00138-19. Print 2019 Jun.

PMID:
30936100
9.

How to make a fast diagnosis in invasive aspergillosis.

Lass-Flörl C.

Med Mycol. 2019 Apr 1;57(Supplement_2):S155-S160. doi: 10.1093/mmy/myy103. Review.

PMID:
30816965
10.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
11.

Erratum to 'High-quality endoscope reprocessing decreases endoscope contamination' [Clinical Microbiology and Infection, Volume 24, Issue 10 (October 2018) Pages 1101.e1-1101.e6].

Decristoforo P, Kaltseis J, Fritz A, Edlinger M, Posch W, Wilflingseder D, Lass-Flörl C, Orth-Höller D; Tyrolean Endoscope Hygiene Surveillance Study Group∗.

Clin Microbiol Infect. 2019 Mar;25(3):396. doi: 10.1016/j.cmi.2019.01.020. Epub 2019 Feb 4. No abstract available.

PMID:
30731205
12.

Candida albicans Factor H Binding Molecule Hgt1p - A Low Glucose-Induced Transmembrane Protein Is Trafficked to the Cell Wall and Impairs Phagocytosis and Killing by Human Neutrophils.

Kenno S, Speth C, Rambach G, Binder U, Chatterjee S, Caramalho R, Haas H, Lass-Flörl C, Shaughnessy J, Ram S, Gow NAR, Orth-Höller D, Würzner R.

Front Microbiol. 2019 Jan 15;9:3319. doi: 10.3389/fmicb.2018.03319. eCollection 2018.

13.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

14.

Galactosaminogalactan (GAG) and its multiple roles in Aspergillus pathogenesis.

Speth C, Rambach G, Lass-Flörl C, Howell PL, Sheppard DC.

Virulence. 2019 Jan 22:1-8. doi: 10.1080/21505594.2019.1568174. [Epub ahead of print]

PMID:
30667338
15.

Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.

Beyer R, Spettel K, Zeller I, Lass-Flörl C, Achleitner D, Krause R, Apfalter P, Buzina W, Strauss J, Gregori C, Schüller C, Willinger B.

Mycoses. 2019 Apr;62(4):357-367. doi: 10.1111/myc.12892. Epub 2019 Feb 20.

PMID:
30636016
16.

Generation of A Mucor circinelloides Reporter Strain-A Promising New Tool to Study Antifungal Drug Efficacy and Mucormycosis.

Binder U, Navarro-Mendoza MI, Naschberger V, Bauer I, Nicolas FE, Pallua JD, Lass-Flörl C, Garre V.

Genes (Basel). 2018 Dec 7;9(12). pii: E613. doi: 10.3390/genes9120613.

17.

Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples.

Arastehfar A, Fang W, Daneshnia F, Al-Hatmi AM, Liao W, Pan W, Khan Z, Ahmad S, Rosam K, Lackner M, Lass-Flörl C, Hagen F, Boekhout T.

Future Microbiol. 2019 Jan;14:33-45. doi: 10.2217/fmb-2018-0227. Epub 2018 Dec 12.

18.

High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patients.

Knabl L, Kuppelwieser B, Mayr A, Posch W, Lackner M, Coraҫa-Huber D, Danita A, Blauth M, Lass-Flörl C, Orth-Höller D.

Microbiologyopen. 2019 Mar;8(3):e00658. doi: 10.1002/mbo3.658. Epub 2018 Dec 3.

19.

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T; from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); European Society of Intensive Care Medicine (ESICM); European Confederation of Medical Mycology (ECMM); Mycoses Study Group Education and Research Consortium (MSGERC).

Mycoses. 2019 Apr;62(4):310-319. doi: 10.1111/myc.12869. Epub 2019 Jan 22.

PMID:
30426598
20.

YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries.

Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, Zomorodian K, Badali H, Hagen F, Lass-Flörl C, Boekhout T.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):112-119. doi: 10.1016/j.diagmicrobio.2018.09.007. Epub 2018 Sep 21.

21.

β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells.

Steger M, Bermejo-Jambrina M, Yordanov T, Wagener J, Brakhage AA, Pittl V, Huber LA, Haas H, Lass-Flörl C, Posch W, Wilflingseder D.

Virulence. 2018 Oct 29:1-13. doi: 10.1080/21505594.2018.1528843. [Epub ahead of print]

PMID:
30372658
22.

Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.

Lackner M, Birch M, Naschberger V, Grässle D, Beckmann N, Warn P, Gould J, Law D, Lass-Flörl C, Binder U.

J Antimicrob Chemother. 2018 Nov 1;73(11):3068-3073. doi: 10.1093/jac/dky329.

PMID:
30351438
23.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

24.

Candida: Platelet Interaction and Platelet Activity in vitro.

Eberl C, Speth C, Jacobsen ID, Hermann M, Hagleitner M, Deshmukh H, Ammann CG, Lass-Flörl C, Rambach G.

J Innate Immun. 2019;11(1):52-62. doi: 10.1159/000491030. Epub 2018 Sep 3.

25.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
26.

Control of hospital-acquired infections in Austria.

Kuppelwieser B, Berktold M, Orth-Höller D, Lass-Flörl C.

Wien Klin Wochenschr. 2018 Nov;130(21-22):673-679. doi: 10.1007/s00508-018-1369-1. Epub 2018 Aug 2. No abstract available.

PMID:
30073546
27.

Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit.

Kreidl P, Mayr A, Hinterberger G, Berktold M, Knabl L, Fuchs S, Posch W, Eschertzhuber S, Obwegeser A, Lass-Flörl C, Orth-Höller D.

Antimicrob Resist Infect Control. 2018 Jul 18;7:86. doi: 10.1186/s13756-018-0374-5. eCollection 2018.

28.

Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.

Vatanshenassan M, Boekhout T, Lass-Flörl C, Lackner M, Schubert S, Kostrzewa M, Sparbier K.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00420-18. doi: 10.1128/JCM.00420-18. Print 2018 Sep.

29.

Treatment of Infections Due to Aspergillus terreus Species Complex.

Lass-Flörl C.

J Fungi (Basel). 2018 Jul 9;4(3). pii: E83. doi: 10.3390/jof4030083. Review.

30.

A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria.

Lass-Flörl C, Mayr A, Aigner M, Lackner M, Orth-Höller D.

Infection. 2018 Oct;46(5):701-704. doi: 10.1007/s15010-018-1170-0. Epub 2018 Jul 3.

31.

Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.

Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U.

Med Mycol. 2019 Apr 1;57(3):351-362. doi: 10.1093/mmy/myy042.

32.

Long-sleeved medical workers' coats and their microbiota.

Berktold M, Mayr A, Obwegeser A, Lass-Flörl C, Kreidl P, Orth-Höller D.

Am J Infect Control. 2018 Dec;46(12):1408-1410. doi: 10.1016/j.ajic.2018.04.230. Epub 2018 May 31.

PMID:
29861149
33.

Sterol Composition of Clinically Relevant Mucorales and Changes Resulting from Posaconazole Treatment.

Müller C, Neugebauer T, Zill P, Lass-Flörl C, Bracher F, Binder U.

Molecules. 2018 May 19;23(5). pii: E1218. doi: 10.3390/molecules23051218.

34.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

35.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

36.

Aspergillus terreus: Novel lessons learned on amphotericin B resistance.

Posch W, Blatzer M, Wilflingseder D, Lass-Flörl C.

Med Mycol. 2018 Apr 1;56(suppl_1):73-82. doi: 10.1093/mmy/myx119. Review.

PMID:
29538736
37.

Correction for Wu et al., "Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling".

Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, Bumann D, Lass-Flörl C, Theurl I, Zhang K, Weiss G.

Infect Immun. 2018 Feb 20;86(3). pii: e00881-17. doi: 10.1128/IAI.00881-17. Print 2018 Mar. No abstract available.

38.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, Kidd S, Pelaez T, Sanguinetti M, Meletiadis J, Botterel F, Bustamante B, Chen YC, Chakrabarti A, Chowdhary A, Chryssanthou E, Córdoba S, Gonzalez GM, Guarro J, Johnson EM, Kus JV, Lass-Flörl C, Linares-Sicilia MJ, Martín-Mazuelos E, Negri CE, Pfaller MA, Tortorano AM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01916-17. doi: 10.1128/AAC.01916-17. Print 2018 Apr.

39.

High-quality endoscope reprocessing decreases endoscope contamination.

Decristoforo P, Kaltseis J, Fritz A, Edlinger M, Posch W, Wilflingseder D, Lass-Flörl C, Orth-Höller D; Tyrolean Endoscope Hygiene Surveillance Study Group.

Clin Microbiol Infect. 2018 Oct;24(10):1101.e1-1101.e6. doi: 10.1016/j.cmi.2018.01.017. Epub 2018 Mar 1. Erratum in: Clin Microbiol Infect. 2019 Mar;25(3):396.

PMID:
29408276
40.

A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients.

Hartl B, Zeller I, Manhart A, Selitsch B, Lass-Flörl C, Willinger B.

Mycopathologia. 2018 Jun;183(3):513-519. doi: 10.1007/s11046-017-0238-1. Epub 2018 Jan 22.

41.

EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.

Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Flörl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA.

Mycoses. 2018 May;61(5):326-330. doi: 10.1111/myc.12746. Epub 2018 Feb 20.

PMID:
29325218
42.

Azole-resistant and -susceptible Aspergillus fumigatus isolates show comparable fitness and azole treatment outcome in immunocompetent mice.

Lackner M, Rambach G, Jukic E, Sartori B, Fritz J, Seger C, Hagleitner M, Speth C, Lass-Flörl C.

Med Mycol. 2018 Aug 1;56(6):703-710. doi: 10.1093/mmy/myx109.

PMID:
29228287
43.

Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase.

Caramalho R, Tyndall JDA, Monk BC, Larentis T, Lass-Flörl C, Lackner M.

Sci Rep. 2017 Nov 21;7(1):15898. doi: 10.1038/s41598-017-16123-9.

44.

In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.

Vaezi A, Fakhim H, Arastehfar A, Shokohi T, Hedayati MT, Khodavaisy S, Rezaei-Matehkolaei A, Badiee P, Hagen F, Lass-Flörl C, Dannaoui E, Meis JF, Badali H.

Mycoses. 2018 Feb;61(2):134-142. doi: 10.1111/myc.12716. Epub 2017 Nov 22.

PMID:
29064123
45.

Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence Studies.

Jukic E, Blatzer M, Binder U, Mayr L, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00755-17. doi: 10.1128/AAC.00755-17. Print 2017 Dec.

46.

Cross-sectional point prevalence survey to study the environmental contamination of nosocomial pathogens in intensive care units under real-life conditions.

Wille I, Mayr A, Kreidl P, Brühwasser C, Hinterberger G, Fritz A, Posch W, Fuchs S, Obwegeser A, Orth-Höller D, Lass-Flörl C.

J Hosp Infect. 2018 Jan;98(1):90-95. doi: 10.1016/j.jhin.2017.09.019. Epub 2017 Sep 28.

PMID:
28964884
47.

Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience.

Lass-Flörl C, Aigner M, Nachbaur D, Eschertzhuber S, Bucher B, Geltner C, Bellmann R, Lackner M, Orth-Höller D, Würzner R, Weiss G, Glodny B.

Infection. 2017 Dec;45(6):867-875. doi: 10.1007/s15010-017-1072-6. Epub 2017 Sep 27.

48.

Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections.

Chandorkar P, Posch W, Zaderer V, Blatzer M, Steger M, Ammann CG, Binder U, Hermann M, Hörtnagl P, Lass-Flörl C, Wilflingseder D.

Sci Rep. 2017 Sep 14;7(1):11644. doi: 10.1038/s41598-017-11271-4.

49.

Salmonella Utilizes Zinc To Subvert Antimicrobial Host Defense of Macrophages via Modulation of NF-κB Signaling.

Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, Bumann D, Lass-Flörl C, Theurl I, Zhang K, Weiss G.

Infect Immun. 2017 Nov 17;85(12). pii: e00418-17. doi: 10.1128/IAI.00418-17. Print 2017 Dec. Erratum in: Infect Immun. 2018 Feb 20;86(3):.

50.

Invasive candidiasis: future directions in non-culture based diagnosis.

Posch W, Heimdörfer D, Wilflingseder D, Lass-Flörl C.

Expert Rev Anti Infect Ther. 2017 Sep;15(9):829-838. doi: 10.1080/14787210.2017.1370373. Epub 2017 Sep 7. Review.

PMID:
28829207

Supplemental Content

Loading ...
Support Center